Evidence map›Paper›PMID 21543326›Full record

ArticleThe Journal of biological chemistry2011

Rab13-dependent trafficking of RhoA is required for directional migration and angiogenesis.

Chuanshen Wu, Sudesh Agrawal, Amit Vasanji, Judy Drazba, Sandeep Sarkaria, Jing Xie, Christopher M Welch, Miaoliang Liu, Bela Anand-Apte, Arie Horowitz

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Role of angiomotin family members in human diseases (Review).Experimental and therapeutic medicine · 2024
    Review
  5. Article
  6. Article
  7. Characterization and computational simulation of human Syx, a RhoGEF implicated in glioblastoma.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  8. Review
  9. Rho GTPases in Retinal Vascular Diseases.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Rabs in Signaling and Embryonic Development.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Hold Me, but Not Too Tight-Endothelial Cell-Cell Junctions in Angiogenesis.Cold Spring Harbor perspectives in biology · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Chuanshen WuDepartment of Molecular Cardiology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195, USA.
Sudesh Agrawal
Amit Vasanji
Judy Drazba
Sandeep Sarkaria
Jing Xie
Christopher M Welch
Miaoliang Liu
Bela Anand-Apte
Arie Horowitz
Cleveland Clinic Lerner College of Medicine · USDartmouth College · USUniversity of North Carolina at Chapel Hill · US

Funding

TRAINING PROGRAM IN VASCULAR CELL BIOLOGYT32HL007914 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN · 1999 to 2011
$2.2M
Role of TIMP-3 in Ocular NeovascularizationR01EY016490 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI ANAND-APTE, BELA · 2005 to 2009
$1.7M
Role of betacellulin in diabetic macular edemaR01EY020861 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI ANAND-APTE, BELA · 2011 to 2014
$1.5M
Leukocyte Transendothelial Migration: Coordination of Rho GTPase SignalingF30HL094020 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WELCH, CHRISTOPHER M · 2008 to 2012
$151k
Evolutionary Genomics of Supersized Mitochondrial GenomesF32GM080079 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI ALVERSON, ANDREW J · 2007 to 2009
$148k
NEI NIH HHS R01 EY016490NEI NIH HHS R01 EY020861NHLBI NIH HHS F30 HL094020NHLBI NIH HHS F30-HL-094020NHLBI NIH HHS HL007914NIGMS NIH HHS F32 GM080079NIGMS NIH HHS T32-GM-80079
6 · The paper itself

Abstract

Angiogenesis requires concomitant remodeling of cell junctions and migration, as exemplified by recent observations of extensive endothelial cell movement along growing blood vessels. We report that a protein complex that regulates cell junctions is required for VEGF-driven directional migration and for angiogenesis in vivo. The complex consists of RhoA and Syx, a RhoA guanine exchange factor cross-linked by the Crumbs polarity protein Mupp1 to angiomotin, a phosphatidylinositol-binding protein. The Syx-associated complex translocates to the leading edge of migrating cells by membrane trafficking that requires the tight junction recycling GTPase Rab13. In turn, Rab13 associates with Grb2, targeting Syx and RhoA to Tyr(1175)-phosphorylated VEGFR2 at the leading edge. Rab13 knockdown in zebrafish impeded sprouting of intersegmental vessels and diminished the directionality of their tip cells. These results indicate that endothelial cell mobility in sprouting vessels is facilitated by shuttling the same protein complex from disassembling junctions to the leading edges of cells.

Indexed as

AnimalsCarrier ProteinsCell MovementEndothelial CellsGRB2 Adaptor ProteinGuanine Nucleotide Exchange FactorsMembrane ProteinsMiceMice, KnockoutNeovascularization, PhysiologicPhosphorylationrab GTP-Binding ProteinsrhoA GTP-Binding Proteinrho GTP-Binding ProteinsTight JunctionsVascular Endothelial Growth Factor ACarrier ProteinsGRB2 Adaptor ProteinGrb2 protein, mouseGuanine Nucleotide Exchange FactorsMembrane ProteinsMpdz protein, mouseRab13 protein, mouserab GTP-Binding ProteinsrhoA GTP-Binding ProteinRhoA protein, mouserho GTP-Binding ProteinsSyx protein, mouseVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID21543326
PMCPMC3123114
OpenAlexW1966113252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.